Trial intelligence / Profile preview

Comparison of Dexmedetomidine and Fentanyl on post-intubation hemodynamic changes

IRCT20191205045619N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Feb 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine and fentanyl in Cardiovascular collapse (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Post-intubation systolic blood pressure, Post-intubation diastolic blood pressure and 2 more. Started Feb 2020; status: completed.

02

Drugs

dexmedetomidinefentanyl
03

Conditions

Cardiovascular collapse

Beyond the preview

Go deeper on IRCT20191205045619N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191205045619N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call